Centiva Capital, LP Horizon Therapeutics Public LTD CO Put Options Transaction History

Centiva Capital, LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $10.8 Million - $12.6 Million	112,500 Added 111.5%	213,400 $21.9 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $5.1 Million - $5.39 Million	47,500 Added 88.95%	100,900 $11 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $3.28 Million - $5.97 Million	52,500 Added 5833.33%	53,400 $6.08 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $53,028 - $76,203	900 New	900 $56,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.